These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9307051)

  • 1. Cocaine abusers do not show loss of dopamine transporters with age.
    Wang GJ; Volkow ND; Fowler JS; Fischman M; Foltin R; Abumrad NN; Logan J; Pappas NR
    Life Sci; 1997; 61(11):1059-65. PubMed ID: 9307051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between subjective effects of cocaine and dopamine transporter occupancy.
    Volkow ND; Wang GJ; Fischman MW; Foltin RW; Fowler JS; Abumrad NN; Vitkun S; Logan J; Gatley SJ; Pappas N; Hitzemann R; Shea CE
    Nature; 1997 Apr; 386(6627):827-30. PubMed ID: 9126740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain.
    Volkow ND; Wang GJ; Fowler JS; Fischman M; Foltin R; Abumrad NN; Gatley SJ; Logan J; Wong C; Gifford A; Ding YS; Hitzemann R; Pappas N
    Life Sci; 1999; 65(1):PL7-12. PubMed ID: 10403500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "high".
    Volkow ND; Wang GJ; Fowler JS; Gatley SJ; Logan J; Ding YS; Dewey SL; Hitzemann R; Gifford AN; Pappas NR
    J Pharmacol Exp Ther; 1999 Jan; 288(1):14-20. PubMed ID: 9862747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users.
    Wilson JM; Levey AI; Bergeron C; Kalasinsky K; Ang L; Peretti F; Adams VI; Smialek J; Anderson WR; Shannak K; Deck J; Niznik HB; Kish SJ
    Ann Neurol; 1996 Sep; 40(3):428-39. PubMed ID: 8797532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans.
    Volkow ND; Fowler JS; Wang GJ
    J Psychopharmacol; 1999 Dec; 13(4):337-45. PubMed ID: 10667609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response and duration effects of acute administrations of cocaine and GBR12909 on dopamine synthesis and transporter in the conscious monkey brain: PET studies combined with microdialysis.
    Tsukada H; Harada N; Nishiyama S; Ohba H; Kakiuchi T
    Brain Res; 2000 Mar; 860(1-2):141-8. PubMed ID: 10727633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of rat dopamine transporter mRNA and protein by chronic cocaine administration.
    Letchworth SR; Sexton T; Childers SR; Vrana KE; Vaughan RA; Davies HM; Porrino LJ
    J Neurochem; 1999 Nov; 73(5):1982-9. PubMed ID: 10537056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of dopamine transporters and rapid adaptation to cocaine.
    Vaughan RA; Huff RA; Uhl GR; Kuhar MJ
    Adv Pharmacol; 1998; 42():1042-5. PubMed ID: 9328076
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-lasting inhibition of in vivo cocaine binding to dopamine transporters by 3 beta-(4-iodophenyl)tropane-2-carboxylic acid methyl ester: RTI-55 or beta CIT.
    Volkow ND; Gatley SJ; Fowler JS; Chen R; Logan J; Dewey SL; Ding YS; Pappas N; King P; MacGregor RR
    Synapse; 1995 Mar; 19(3):206-11. PubMed ID: 7784960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine transport function is elevated in cocaine users.
    Mash DC; Pablo J; Ouyang Q; Hearn WL; Izenwasser S
    J Neurochem; 2002 Apr; 81(2):292-300. PubMed ID: 12064476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine.
    Desai RI; Kopajtic TA; Koffarnus M; Newman AH; Katz JL
    J Neurosci; 2005 Feb; 25(8):1889-93. PubMed ID: 15728828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo labeling of cocaine binding sites on dopamine transporters with [3H]WIN 35,428.
    Scheffel U; Pögün S; Stathis M; Boja JW; Kuhar MJ
    J Pharmacol Exp Ther; 1991 Jun; 257(3):954-8. PubMed ID: 2046028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference.
    Sora I; Hall FS; Andrews AM; Itokawa M; Li XF; Wei HB; Wichems C; Lesch KP; Murphy DL; Uhl GR
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5300-5. PubMed ID: 11320258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further structurally constrained analogues of cis-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transporters.
    Kolhatkar R; Cook CD; Ghorai SK; Deschamps J; Beardsley PM; Reith ME; Dutta AK
    J Med Chem; 2004 Oct; 47(21):5101-13. PubMed ID: 15456254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the mechanism of inhibition of the dopamine uptake carrier by cocaine in vitro using rotating disk electrode voltammetry.
    McElvain JS; Schenk JO
    Ann N Y Acad Sci; 1992 Jun; 654():480-2. PubMed ID: 1632608
    [No Abstract]   [Full Text] [Related]  

  • 17. Brain dopamine transporter messenger RNA and binding sites in cocaine users: a postmortem study.
    Little KY; McLaughlin DP; Zhang L; McFinton PR; Dalack GW; Cook EH; Cassin BJ; Watson SJ
    Arch Gen Psychiatry; 1998 Sep; 55(9):793-9. PubMed ID: 9736005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration and occupancy of dopamine transporters in cocaine abusers with [11C]cocaine and PET.
    Logan J; Volkow ND; Fowler JS; Wang GJ; Fischman MW; Foltin RW; Abumrad NN; Vitkun S; Gatley SJ; Pappas N; Hitzemann R; Shea CE
    Synapse; 1997 Dec; 27(4):347-56. PubMed ID: 9372557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid regulation of the dopamine transporter: role in stimulant addiction?
    Zahniser NR; Sorkin A
    Neuropharmacology; 2004; 47 Suppl 1():80-91. PubMed ID: 15464127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [125I]RTI-55: a potent ligand for dopamine transporters.
    Boja JW; Patel A; Carroll FI; Rahman MA; Philip A; Lewin AH; Kopajtic TA; Kuhar MJ
    Eur J Pharmacol; 1991 Feb; 194(1):133-4. PubMed ID: 2060590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.